1. Introduction {#sec0005}
===============

Necrotising fasciitis (NF) is a bacterial inflammation of the fascia leading to necrosis of the underlying soft tissue and fascial layers. It is associated with a high mortality rate of approximately 25% \[[@bib0005]\]. Thankfully it is very rare, with approximately 500 reported cases annually in the UK \[[@bib0010]\]. It most commonly affects the superficial fascial layers of the extremities, the abdomen or the perineum and is commonly associated with an initial traumatic injury \[[@bib0015]\]. Furthermore, patient co-morbidities increase the risk of developing NF. These include diabetes, immunosuppression and frailty \[[@bib0005]\]. Cases of necrotising fasciitis of the breast (NFB) are even rarer, with very few reports in the literature (discussed below).

NF can be subdivided into two subtypes. Type 1 is a polymicrobial infection where organisms, such as *Staphylococcus aureus and Escherichia coli,* act synergistically. Type 2 involves haemolytic Group A streptococcus +/− staphylococci infection and is the more severe \[[@bib0020]\].

The clinical features associated with NF are erythema, localised inflammation and pain at the infection site. Pain is often disproportionate to examination findings and serves as a warning sign to underlying NF \[[@bib0010]\]. The characteristic skin changes classically associated with NF are typically a late sign. The initial erythema of the skin, which can easily be confused for cellulitis, becomes increasingly purple before finally turning dusky blue. Necrosis then begins to develop and haemorrhagic bullae may form \[[@bib0010]\]. Its most-worrying complication is systemic shock which can lead to Multiple Organ Dysfunction Syndrome and death. With NFB the symptoms in their early stages can often mimic breast cellulitis, with difficulty in distinguishing clinically between the two.

The main principles of treatment are broad-spectrum antibiotics with debridement of the necrotic tissue. Traditionally the diagnosis is made clinically with little use of radiological imaging.

The following case report is written in accordance with the Surgical Case Report (SCARE) 2018 guidance to increase transparency and accuracy in case report publication \[[@bib0025]\]. Consent was achieved from the patient to publish this case report.

2. Literature review {#sec0010}
====================

Necrotising fasciitis of the breast (NFB) is rare with few case reports in the literature. A summary of the case reports found on a literature search for "Necrotising Fasciitis" and "Breast" on Medline is displayed below ([Table 1](#tbl0005){ref-type="table"}).Table 1Summary of necrotising fasciitis cases found in the literature.Table 1CaseMedical historyPresentationCausative organismsImagingManagementOutcomeTillett et al. \[[@bib0030]\]35Right breast pain with local erythema and inflammation and diarrhoea and vomitingGroup A streptococcalNoneIV Clindamycin and Imipenem; and IV polyspecific immunoglobulinSurvived10 days post-partum and breastfeedingSurgical debridementVishwanath et al. \[[@bib0035]\]20Discolouration and purulent discharge from the right breast with a feverNot mentionedNoneIV piperacillin-tazobactum (tazocin) and metronidazoleSurvived20 days post-partumRight mastectomyShah et al. \[[@bib0040]\]50Pain, fever and chills with a palpable lump in the right breastGram positive rods & Gram positive cocciNoneIV Co-AmoxiclavSurvivedType 2 diabetes mellitus (T2DM)Right mastectomyRajakannu et al. \[[@bib0045]\]50Septic with a necrotic, purulent ulcer of the right breastPolymicrobialNoneIV crystalline penicillin, ceftriaxone and metronidazoleSurvivedNo co-morbiditiesRight mastectomyFlandrin et al. \[[@bib0050]\]50Left breast pain and swelling with a fever and chillsβ-hemolytic streptococciMRI - Reticular increased signal intensity of the skin, subcutaneous tissues, and superﬁcial fasciaIV cefotaxime, metronidazole and linezolidSurvivedStereotactic needle biopsy one week previouslySurgical debridementKaczynski et al. \[[@bib0055]\]75Painful, erythematous and swollen left breast with sepsisMixed growths of anaerobes, viridans-type *Streptococcus* and coagulase-negative *Staphylococcus*NoneIV cefuroxime and metronidazoleSurvivedHypertension (HTN)Initial debridement unsuccessful followed by partial mastectomy.Yaji et al. \[[@bib0060]\]55Pain and swelling in the left breast with a high grade fever and septic shockPolymicrobial growthNoneIV tazocin and metronidazoleDiedT2DM and HTN*E. coli* and *Pseudomonas*Left mastectomyYang et al. \[[@bib0065]\]30Pain, swelling and inflammation of the left breast with marked cellulitis plus febrileInvasive Group A *Streptococcus* & *Staphylococcus aureus*NoneIV gentamicin, clindamycin, teicoplanin and metronidazoleSurvivedNo co-morbiditiesNipple-sparing left mastectomyFayman et al. \[[@bib0070]\]23Pain and swelling in the right breast with discolouration and nipple discharge.*Streptococcus pyogenes*NoneIV meropenem, clindamycin and vancomycinSurvivedObesity and polycystic ovarian syndromeRight mastectomySoliman et al. \[[@bib0075]\]61Few days h/o painful swollen breast, discharge of pus and fever*Pseudomonas aeruginosa*, *Proteus mirabili*s and *Klebsiella pneumoniae*NoneDalacin,Lincomycin converted to Tazocin on diagnosisSurvivedNo co-morbiditiesExtensive debridementMarongiu et al. \[[@bib0080]\]39Painful swelling of breast and feverGroup A *Streptococcus pyogenes*CT - subdermal oedemaExtensive debridement and Hyperbaric oxygen followed by skin graftingSurvivedNo co-morbiditiesKeune et al. \[[@bib0085]\]47Fever, chills and night sweats with black malodorous area of left breastMixed microorganisms - Gram negative and positive bacilli and Gram positive cocci. *Strep anginosus constellatus intermedius*CT - skin thickening and subcutaneous gas trackingVancomycin, Tazocin & ClindamycinSurvivedNo co-morbiditiesExtensive debridement followed by simple mastectomyKhatri et al. \[[@bib0090]\]35Progressively enlarging swelling of right breast*Klebsiella* sp.NoneIV tazocinSurvivedNo co-morbiditiesRegular wound debridement

3. Case presentation {#sec0015}
====================

A 54 year-old lady with a background of poorly controlled tablet-controlled type II diabetes mellitus (HbA1c = 108) and obesity was admitted with an atraumatic, painful right breast lump which had been present for five days to a medium-sized district general hospital. The lump was becoming increasingly painful and she had recently developed fevers. She was initially treated as a breast abscess with IV flucloxacillin due to raised inflammatory markers, with a white cell count (WCC) 15.25 and CRP 301.5. An USS was arranged which showed a "*superficial infection with surrounding oedema but no collection or abscess*". On the second day her WCC began to fall with intravenous antibiotic therapy but her CRP continued to rise with her pain intensifying and erythema spreading. Her antibiotics were therefore changed to include IV clindamycin on microbiology advice.

On day four of admission a repeat USS was requested due to worsening erythema. This showed "*spreading skin thickening and oedema of the whole breast skin*" but no demonstrable collection. Her blood results returned later that day with a CRP of 611 and an acute kidney injury. In light of the blood results and her deteriorating condition she was reviewed by the breast team. Her LRINEC score (a calculator of probability of NF) was calculated as 9 \[[@bib0095]\] and an urgent CT thorax was booked. This was completed within an hour and demonstrated a "*large volume of interstitial soft tissue gas throughout the right breast with diffuse fat stranding*" (see [Fig. 1](#fig0005){ref-type="fig"}). This was thought to be consistent with necrotising fasciitis of the breast and once clinically stabilised, she was consented and taken to theatre for urgent debridement of the necrotic tissue by two breast consultants.Fig. 1CT imaging of right breast demonstrating extensive soft tissue gas.Fig. 1

Intraoperatively, necrotic fat was found in the right lower inner quadrant extending to the subareolar region. This did not extend to the lateral breast or the abdominal wall and the pectoral muscle was healthy. Microbiology swabs were sent which came back positive for *Enterococcus faecalis* sensitive to amoxicillin and pieracillin/tazobactam (tazocin). This is consistent with Type I necrotising fasciitis. The histological specimen showed extensive necrosis and purulent inflammation in keeping with necrotising fasciitis. The wound was initially left open with a planned re-look two days later.

Post-operatively she was transferred to ITU. Her antibiotics were changed to IV tazocin and clindamycin on microbiology advice, with the tazocin continuing for fourteen days in total. In total, she spent seven days on ITU requiring vasopressor support and temporary dialysis as well as ventilatory support.

Her second look operation, two days after the first, involved a washout plus excision of some medial necrotic skin. The wound was packed and the skin left loosely closed. She returned for a third look operation six days after the initial operation which showed no further necrotic tissue so the wound was washed and the skin was closed using an abdominal advancement flap ([Fig. 2](#fig0010){ref-type="fig"}).Fig. 2Post-operative picture after first re-look operation (left). Three months after surgery (right).Fig. 2

4. Discussion {#sec0020}
=============

Necrotizing fasciitis rarely develops in the breast, with its more common sites being the scrotum, abdominal wall, extremities and perineum. In the case described above it is the authors' consideration that the bacteria selectively infected Cooper's suspensory ligaments of the breast, leading to the delay in skin changes and relative preservation of both the superficial and deep fascial layers. It is also likely that this lady's poorly controlled T2DM contributed to her presentation, leading to an immunocompromised state, predisposing her to spontaneous infection.

Due to the rarity of the condition, the diagnosis is often delayed. This results in an unclear management plan with uncontrolled disease progression prior to debridement. The LRINEC score can be calculated to aid in the probability of a case being NF \[[@bib0095]\]. A golden six point management plan for NFB was recommended by Shah et al. \[[@bib0040]\], which followed the management plan set out by Ward et al. \[[@bib0100]\] for general management of necrotising fasciitis.(1)Early surgical referral for disproportionate pain and cellulitis(2)Broad-spectrum antibiotics and intravenous fluid resuscitation(3)Exploratory diagnostic incision to inspect the fascia(4)Radical debridement(5)Re-exploration of the wound within 24 h of first surgery(6)Involvement of plastic surgeons for reconstructive options.

The literature search suggests that both medical and surgical management is consistently the same with use of empirical antibiotics and debridement, but that problems arise in the diagnosis stage. Notably the use of imaging was incredibly variable with only three cases (23%) using any form of diagnostic imaging. Imaging is not mentioned by Shah et al. \[[@bib0040]\], most likely because CT imaging was not as widely available as it now is. This may also be due to a clearer initial diagnosis due to late presentation. In cases where the initial diagnosis is unclear this leads us to believe that further cross-sectional imaging, such as a CT scan, would allow prompt diagnosis of NFB. In our case described above this proved to be the diagnostic feature as our patient did not have the characteristic skin changes classically described in the literature. Reviewing the cases where imaging was used it often helped to confirm the diagnosis and allow a targeted approach to debridement. Marongiu et al. \[[@bib0080]\] initially diagnosed their patient with breast mastitis but changed their diagnosis once a CT scan was performed. This led to prompt debridement of the infected area. In the case of Keune et al. \[[@bib0085]\] it identified the extent of necrotising tissue and an initial more conservative debridement. This was ultimately unsuccessful and the patient had to have a mastectomy but it allowed the opportunity for a potentially less invasive surgery first of all.

We therefore think it is important that surgeons and clinicians hold a high index of suspicion when a patient presents with fever and disproportionate pain in the breast so that in these scenarios early cross-sectional imaging is carried out to ensure optimal management of the patient. As demonstrated in our case this more accurately diagnoses NFB than breast USS.

Consequentially we have created a simple diagnostic (see [Fig. 3](#fig0015){ref-type="fig"}) and management triad for NFB (see [Fig. 4](#fig0020){ref-type="fig"}) which is a modification of the 6 point management plan devised by Shah et al. \[[@bib0040]\].Fig. 3Clinical diagnostic triad for NFB: \*where pain is disproportionate to signs; \*\*also includes a swollen or oedematous breast.Fig. 3Fig. 4Management triad for NFB: \*with IV fluids and broad spectrum antibiotics; \*\*Imaging: CT/MRI; \*\*\*Surgery: Extensive debridement.Fig. 4

5. Conclusion {#sec0025}
=============

In conclusion, we believe that necrotising fasciitis of the breast is a very challenging diagnosis for a clinician to make due to its rarity and similarity with a simple breast infection. Clinicians must hold a high index of suspicion if pain is disproportionate to the signs or a painful swollen breast co-presents with sepsis. Further to this we believe that this case highlights the importance of urgent cross-sectional imaging of the breast, if there is doubt over the diagnosis, to avoid any delay in treatment and to allow a more targeted approach to the subsequent debridement.
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